ERNA stock · KEYS stock

ERNA vs KEYS

Eterna Therapeutics Inc (ERNA) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.

Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.

Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.

Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.

Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.

ERNA currently screens at market cap $6.9M and trailing P/E 0.0. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.

Not investment advice. Open the ERNA and KEYS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons